This kind of drug resistance in breast cancer is associated with several biochemical changes, including yjr overexpression of numerous proteins, such as ATP-binding cassette transporters, P-glycoprotein (P-gp), multidrug resistance-associated proteins MRP1 and MRP2 and breast cancer resistance protein (BCRP) [107]. Here, ABCG2 is linked to breast cancer.